Funding
Researcher : Miguel Fernández de Sanmamed Gutiérrez
12 funding - 4,995,375€
2023
-
HUMANIZED-PDX MODELS TO DEVELOP IL-8/CXCR AND CD137 TARGETING THERAPIES TO OVERCOME RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS IN SKIN AND KIDNEY CANCER PATIENTS
euro 1,250,000.00
-
Humanized-PDX models to support Treg targeting drugsdevelopm
euro 150,013.00
-
Células dendríticas decross-priming como vacunas en una estrategia de inmunoterapia para cánceres renales y de urotelio.
euro 1,007,600.00
-
NAV-22 CD25 imCORE Research agreement
euro 68,000.00
-
Plataforma para la Identificación de TCR Específicos de Antígenos Tumorales para la Inmunoterapia de Tumores Sólidos (PITAGORAS)
euro 474,228.00
2022
2021
2020
2018
-
Humanised-mouse models to implement immunotherapy of cancer
euro 100,000.00